Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas
暂无分享,去创建一个
M. Colonna | M. Cella | S. Sozzani | W. Vermi | F. Facchetti | R. Bonecchi | A. Berenzi | S. Festa | D. Bianchi
[1] T. Blankenstein,et al. Cross-priming versus cross-tolerance: are two signals enough? , 2002, Trends in immunology.
[2] Antonio Lanzavecchia,et al. BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.
[3] T. Curiel,et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells , 2001, Nature Medicine.
[4] L. Adorini,et al. Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells1 , 2001, The Journal of Immunology.
[5] F. Lund-Johansen,et al. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.
[6] Frank O. Nestle,et al. Dendritic cells: On the move from bench to bedside , 2001, Nature Medicine.
[7] M. Jefford,et al. The use of dendritic cells in cancer therapy. , 2001, The Lancet. Oncology.
[8] M. Carrington,et al. A Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin (Dc-Sign)–Related Protein Is Highly Expressed on Human Liver Sinusoidal Endothelial Cells and Promotes HIV-1 Infection , 2001, The Journal of experimental medicine.
[9] A. Palucka,et al. Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells , 2000, The Journal of experimental medicine.
[10] S. Miltenyi,et al. BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.
[11] F. Lund-Johansen,et al. Experimentally Induced Recruitment of Plasmacytoid (CD123high) Dendritic Cells in Human Nasal Allergy1 , 2000, The Journal of Immunology.
[12] A. Lanzavecchia,et al. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization , 2000, Nature Immunology.
[13] Carl G. Figdor,et al. DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking , 2000, Nature Immunology.
[14] D. Rigel,et al. Malignant melanoma: Prevention, early detection, and treatment in the 21st century , 2000, CA: a cancer journal for clinicians.
[15] C. Figdor,et al. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.
[16] S Gordon,et al. Macrophage lectins in host defence. , 2000, Microbes and infection.
[17] P. Dalerba,et al. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] Nina Bhardwaj,et al. Consequences of cell death: exposure to necrotic tumor cells , 2000 .
[19] J. Banchereau,et al. In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas , 1999, The Journal of experimental medicine.
[20] Stefania Gallucci,et al. Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.
[21] Rong-Fu Wang,et al. Human tumor antigens: implications for cancer vaccine development , 1999, Journal of Molecular Medicine.
[22] J. Banchereau,et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface , 1999, European journal of immunology.
[23] D. Jarrossay,et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.
[24] W. Vermi,et al. Plasmacytoid monocytes express IL3‐receptor alpha and differentiate into dendritic cells , 1999, Histopathology.
[25] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[26] N. Yawalkar,et al. Characterization of human skin-derived CD1a-positive lymph cells , 1999, Archives of Dermatological Research.
[27] J. Banchereau,et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. , 1998, Immunity.
[28] T. Yoshino,et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. , 1998, The American journal of pathology.
[29] C. Caux,et al. Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.
[30] F. Nestle,et al. Human dermal dendritic cells process and present soluble protein antigens. , 1998, The Journal of investigative dermatology.
[31] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[32] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[33] R. Steinman,et al. Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.
[34] C Caux,et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. , 1997, Blood.
[35] J. Banchereau,et al. The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand , 1997, The Journal of experimental medicine.
[36] J. Banchereau,et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.
[37] C Danieli,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[38] D. Fivenson,et al. Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis , 1995, Journal of cutaneous pathology.
[39] M. Fey,et al. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. , 1995, Blood.
[40] J U Gutterman,et al. Cytokine therapeutics: lessons from interferon alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Thompson,et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. , 1993, Journal of immunology.
[42] G. Schuler,et al. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. , 1993, The Journal of clinical investigation.
[43] A. Cochran,et al. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. , 1993, The Journal of investigative dermatology.
[44] G. Halliday,et al. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. , 1991, The Journal of investigative dermatology.
[45] B. Nickoloff,et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin , 1989, The British journal of dermatology.
[46] V. Desmet,et al. Anti-high endothelial venule monoclonal antibody HECA-452 recognizes plasmacytoid T cells and delineates an "extranodular" compartment in the reactive lymph node. , 1989, Immunology letters.
[47] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[48] V. Desmet,et al. Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. , 1988, The American journal of pathology.
[49] V. Desmet,et al. Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study. , 1988, Human pathology.
[50] A. Cochran,et al. Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin. , 1988, The Journal of investigative dermatology.
[51] D. Mason,et al. Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas , 2004, Virchows Archiv A.
[52] G. Schuler,et al. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system , 2004, Springer Seminars in Immunopathology.
[53] S. Imamura,et al. CD 34 + Hematopoietic Progenitors from Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to GM-CSF + TNFoL , 2003 .
[54] J. Davoust,et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. , 2000, Immunity.
[55] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.
[56] A. Palangié,et al. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas. , 1995, Invasion & metastasis.
[57] P. Bruggen,et al. Tumor antigens recognized by T lymphocytes. , 1994, Annual review of immunology.
[58] P. Staeheli. Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.